bluebird bio, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
bluebird bio, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2018 to Q1 2024.
  • bluebird bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $64.6M, a 43.9% decline year-over-year.
  • bluebird bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $196M, a 1020% increase from 2022.
  • bluebird bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $17.5M.
  • bluebird bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$94M, a 117% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $64.6M -$50.5M -43.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-09-13
Q1 2023 $115M +$115M Jan 1, 2023 Mar 31, 2023 10-Q 2024-09-13
Q1 2022 $9K* -$3.79M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $3.8M +$2.83M +294% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $963K -$9.26M -90.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $10.2M -$61.5M -85.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $71.7M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.